Granisetron Market by Product Type, Application, End Users, Distribution Channel - Global Forecast 2025-2030- Product Image

Sale

Granisetron Market by Product Type, Application, End Users, Distribution Channel - Global Forecast 2025-2030

Report
191 Pages
October 2024
Region: Global
360iResearch™
ID: 6017482

UP TO €668EUR$697USD£557GBP OFF until Dec 31^st 2024

The Granisetron Market grew from USD 7.01 billion in 2023 to USD 7.43 billion in 2024. It is expected to continue growing at a CAGR of 6.58%, reaching USD 10.96 billion by 2030.

Granisetron, a serotonin 5-HT3 receptor antagonist, is primarily used as an antiemetic to prevent chemotherapy- and radiotherapy-induced nausea and vomiting, and in some cases for postoperative nausea. The market scope of Granisetron spans its applications in oncology, surgical settings, and potentially in gastroenterology. Its necessity is high in oncology to improve quality of life and adherence to cancer treatments by mitigating side effects. End-use applications involve hospitals, cancer treatment centers, and outpatient surgical facilities. A critical market growth driver is the increasing prevalence of cancer and advancements in chemotherapy treatments requiring effective antiemetic drugs. Potential opportunities lie in the expansion of Granisetron use in developing regions with rising cancer cases and improving healthcare infrastructure. Additionally, exploring new delivery methods such as transdermal patches or orally disintegrating tablets could enhance patient compliance and expand market share.

However, the market faces limitations such as side effects associated with the drug, regulatory challenges, and competition from other antiemetics, including newer biologics with broader efficacy. Additionally, the patent expiration of Granisetron can lead to an influx of generic competitors, impacting market pricing and profitability. Challenging factors include regulatory hurdles and the need for robust clinical trials to expand its approved uses. To navigate these challenges, the best areas for innovation include research on alternative applications of Granisetron in other nausea-related conditions or combination therapies to enhance efficacy. Insights on the market indicate a mature yet dynamic landscape, with ongoing need for innovations to maintain competitiveness. Companies should focus on strategic partnerships, investing in emerging markets, and continuous research to capitalize on these opportunities. Overall, balancing innovation with cost management and regulatory compliance will be key strategies in driving business growth in the Granisetron market.

Understanding Market Dynamics in the Granisetron Market

The Granisetron Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
- Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
- Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
- Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
Market Restraints
- Navigating patent expirations and their impact on Granisetron market dynamics
Market Opportunities
- Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
- Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
- Integrating granisetron into personalized medicine approaches for better patient outcomes
Market Challenges
- Supply chain vulnerabilities impacting the consistent availability of Granisetron

Exploring Porter’s Five Forces for the Granisetron Market

Porter’s Five Forces framework further strengthens the insights of the Granisetron Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Granisetron Market

External macro-environmental factors deeply influence the performance of the Granisetron Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Granisetron Market

The Granisetron Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Granisetron Market

The Granisetron Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Granisetron Market

The Granisetron Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Granisetron Market, highlighting leading vendors and their innovative profiles. These include Akorn, Allergan, Amgen, Apotex, Aurobindo Pharma, Baxter International, Cipla, Dr. Reddy's Laboratories, Endo International, Fresenius Kabi, Glenmark Pharmaceuticals, Hoffmann-La Roche, Lupin Pharmaceuticals, Mylan, Natco Pharma, Pfizer, Sandoz, Sun Pharmaceutical, Teva Pharmaceuticals, and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Granisetron Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Injectable Solution
- Oral Solution
Application
- Chemotherapy-Induced Nausea And Vomiting
- Postoperative Nausea And Vomiting
- Radiotherapy-Induced Nausea And Vomiting
End Users
- Clinics
  - General Clinics
  - Oncology Clinics
- Homecare
- Hospitals
  - Private Hospitals
  - Public Hospitals
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
5.1.1.2. Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
5.1.1.3. Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
5.1.1.4. Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
5.1.2. Restraints
5.1.2.1. Navigating patent expirations and their impact on Granisetron market dynamics
5.1.3. Opportunities
5.1.3.1. Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
5.1.3.2. Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
5.1.3.3. Integrating granisetron into personalized medicine approaches for better patient outcomes
5.1.4. Challenges
5.1.4.1. Supply chain vulnerabilities impacting the consistent availability of Granisetron
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Granisetron Market, by Product Type

6.1. Introduction
6.2. Injectable Solution
6.3. Oral Solution

7. Granisetron Market, by Application

7.1. Introduction
7.2. Chemotherapy-Induced Nausea And Vomiting
7.3. Postoperative Nausea And Vomiting
7.4. Radiotherapy-Induced Nausea And Vomiting

8. Granisetron Market, by End Users

8.1. Introduction
8.2. Clinics
8.2.1. General Clinics
8.2.2. Oncology Clinics
8.3. Homecare
8.4. Hospitals
8.4.1. Private Hospitals
8.4.2. Public Hospitals

9. Granisetron Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Granisetron Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Granisetron Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Granisetron Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. GRANISETRON MARKET RESEARCH PROCESS
FIGURE 2. GRANISETRON MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. GRANISETRON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GRANISETRON MARKET DYNAMICS
TABLE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GRANISETRON MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GRANISETRON MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GRANISETRON MARKET SIZE, BY RADIOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GRANISETRON MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GRANISETRON MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GRANISETRON MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GRANISETRON MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GRANISETRON MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 50. CANADA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. CANADA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. CANADA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CHINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. CHINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CHINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 82. CHINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 83. CHINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. CHINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. INDIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. INDIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 88. INDIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 89. INDIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 90. INDIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. JAPAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. JAPAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. JAPAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 100. JAPAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. THAILAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. THAILAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. THAILAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 136. THAILAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. DENMARK GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EGYPT GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. EGYPT GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 161. EGYPT GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. FINLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 167. FINLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. FRANCE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. GERMANY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. GERMANY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. ITALY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. ITALY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 191. ITALY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 192. ITALY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. ITALY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. NORWAY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. NORWAY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NORWAY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 209. NORWAY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. POLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. POLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. POLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 215. POLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 216. POLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. POLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. QATAR GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 221. QATAR GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 222. QATAR GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. QATAR GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SPAIN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. TURKEY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
TABLE 279. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Granisetron Market, which are profiled in this report, include:

Akorn
Allergan
Amgen
Apotex
Aurobindo Pharma
Baxter International
Cipla
Dr. Reddy's Laboratories
Endo International
Fresenius Kabi
Glenmark Pharmaceuticals
Hoffmann-La Roche
Lupin Pharmaceuticals
Mylan
Natco Pharma
Pfizer
Sandoz
Sun Pharmaceutical
Teva Pharmaceuticals
Wockhardt

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	191
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.43 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.96 Billion
Compound Annual Growth Rate	6.5%
Regions Covered	Global
No. of Companies Mentioned	21

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3397EUR$3,545USD£2,831GBP €3775EUR$3,939USD£3,145GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6011EUR$6,272USD£5,009GBP €6679EUR$6,969USD£5,565GBP

Understanding Market Dynamics in the Granisetron Market

Exploring Porter’s Five Forces for the Granisetron Market

Applying PESTLE Analysis to the Granisetron Market

Analyzing Market Share in the Granisetron Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Granisetron Market

Strategic Recommendations for Success in the Granisetron Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Granisetron Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2022)

Granisetron (CAS 109889-09-0) Global Market Research Report 2024

Chemotherapy Induced Nausea And Vomiting Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024

Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report